Farmer Mac to issue $100 million of Series H preferred stock

Federal Agricultural Mortgage Corporation (Farmer Mac) announced a $100 million public offering of 6.500% non-cumulative perpetual Series H preferred stock, aimed at bolstering its Tier 1 capital, with closing anticipated by August 25, 2025. This capital raise follows the company's robust Q2 2025 performance, which saw revenue of $102.63 million significantly exceed forecasts by 34.83%, though the stock experienced a slight decline despite these strong operational results.

Analysis

Federal Agricultural Mortgage Corporation (AGM) has demonstrated robust operational performance in its second quarter of 2025, with revenue of $102.63 million significantly outperforming the forecast of $76.12 million by 34.83%. This strong top-line result was complemented by an earnings per share of $4.32, narrowly beating analyst expectations. Despite these positive fundamentals, the company's common stock registered a slight decline, a divergence that may be attributable to broader market weakness or investor reaction to a simultaneous capital structure event. Specifically, Farmer Mac is bolstering its balance sheet by issuing $100 million in new 6.500% non-cumulative perpetual Series H preferred stock. This move is designed to increase its Tier 1 capital, a key measure of financial stability, and supports its long-term strategy of providing liquidity to the agricultural sector. The company’s financial discipline is further underscored by its 22-year history of consistent dividend payments on its common stock, which currently yields 3.08%.

Key Decisions for Investors

• Investors should evaluate the disconnect between the company's strong fundamental results, including a significant revenue beat, and the recent minor decline in its common stock price.
• Consider the new 6.500% Series H preferred stock as a distinct income-focused opportunity, while assessing its impact on the company's overall cost of capital and financial structure.
• Monitor future earnings reports to confirm if the capital infusion from the preferred offering translates into sustained growth and margin protection, validating the current operational momentum.